All patients were pathologically diagnosed with ER+HER2− stage I–II IDC or DCIS, according to the BC biologic subtype and TNM anatomic stage classification from AJCC UICC (8th edition). Here, ERBB2 is linked to ductal breast carcinoma in situ.